ED-Home Pilot Study

July 26, 2022 updated by: NYU Langone Health

ED-Home: A Pilot Feasibility Study of a Homelessness Prevention Intervention for Substance Using Emergency Department Patients

This is a single-arm pilot study to test the feasibility of homelessness prevention and substance use interventions to be delivered to at-risk patients in the Bellevue Hospital emergency department (ED). ED patients (n=40) found eligible for the study will complete a baseline assessment and receive referrals to appropriate services, with a final six-month follow-up assessment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

ED patients found eligible for the study will complete a baseline survey and receive one-time, in person services at the time of the baseline/enrollment ED visit including referrals to homelessness prevention and substance use services, with a final six-month follow-up survey. Interim contacts at 7-10 days, 3 months, and 5 months will be used to assure intervention components were received and to confirm participant contact information.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • New York
      • New York, New York, United States, 10016
        • New York University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 99 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be a patient in the Bellevue Hospital Center ED.
  • Be ≥18 years old.
  • Screen positive for homelessness risk using a homelessness risk screening tool (HRST).
  • Screen positive for unhealthy alcohol or drug use.
  • Able to provide consent.

Exclusion Criteria:

  • Medically (e.g., critically ill) or psychiatrically unstable.
  • Unable to provide informed consent for other reason (e.g., cognitive deficit, profound intoxication).
  • Incarcerated or in police custody.
  • Unable to understand and speak English.
  • Lives outside NYC and/or cannot give a NYC ZIP code.
  • Already homeless (residing in a shelter or on the streets).
  • Does not have a telephone where can be reached for follow-up.
  • Has already received specialized peer navigator/addiction social worker services during current ED visit.
  • Has already participated in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Homelessness Prevention Services
Behavioral: Referral to homelessness prevention services
Referral to Homebase homelessness prevention services offered by community-based organizations in NYC
Behavioral: Substance use services
Referral to substance use services (SBIRT and peer counselor/social work contact) available at Bellevue Hospital
Behavioral: Follow-up
Follow-up to assist participants in receiving homelessness prevention services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Percentage of Potential Participants Approached Who Were Eligible for the Study
Time Frame: Month 6
Month 6
Percentage of Eligible Participants Who Agreed to Participate in the Study
Time Frame: Month 6
Month 6
Number of Participants Who Received Referrals for Homelessness Prevention and/or Substance Use Services
Time Frame: Month 6
Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NYU Langone Health

Collaborators

National Institute on Drug Abuse (NIDA)

Investigators

  • Principal Investigator: Kelly Doran, MD, MHS, New York Langone Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 8, 2019

Primary Completion (ACTUAL)

March 23, 2020

Study Completion (ACTUAL)

March 23, 2020

Study Registration Dates

First Submitted

March 4, 2019

First Submitted That Met QC Criteria

March 4, 2019

First Posted (ACTUAL)

March 6, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 19, 2022

Last Update Submitted That Met QC Criteria

July 26, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 18-02040
  • K23DA039179 (NIH)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Drug Use

Clinical Trials on Referral to homelessness prevention services

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe